Achievement of normoglycemia with tirzepatide in type 2 diabetes mellitus: A step closer to drug-induced diabetes remission?

被引:2
|
作者
Popovic, Djordje S. [1 ,2 ]
Patoulias, Dimitrios [1 ]
Koufakis, Theocharis [2 ]
Stavropoulos, Konstantinos [2 ]
Karakasis, Paschalis [3 ]
Ruza, Ieva [4 ]
Papanas, Nikolaos [5 ]
Rizzo, Manfredi [6 ]
Doumas, Michael [2 ]
机构
[1] Univ Novi Sad, Med Fac, Clin Ctr Vojvodina, Clin Endocrinol Diabet & Metab Disorders, Novi Sad, Serbia
[2] Aristotle Univ Thessaloniki, Gen Hosp Hippokration, Propedeut Dept Internal Med 2, Thessaloniki, Greece
[3] Aristotle Univ Thessaloniki, Gen Hosp Hippokration, Dept Cardiol 2, Thessaloniki, Greece
[4] Riga Eastern Clin Univ Hosp, Dept Endocrinol, Riga, Latvia
[5] Democritus Univ Thrace, Univ Hosp Alexandroupolis, Diabet Ctr, Dept Internal Med 2, Alexandroupolis, Greece
[6] Univ Palermo, Sch Med, Dept Hlth Promot Mother & Child Care Internal Med, Palermo, Italy
关键词
Tirzepatide; Type; 2; diabetes; Normoglycemia; INSULIN GLARGINE; GLYCEMIC CONTROL; DOUBLE-BLIND; MANAGEMENT; PLACEBO; GLP-1; GIP;
D O I
10.1016/j.jdiacomp.2024.108800
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We sought to determine whether treatment with tirzepatide in type 2 diabetes mellitus (T2DM) patients can increase the odds for achieving normoglycemia, compatible with glycated hemoglobin levels lower than 5.7 %. We demonstrated that treatment with tirzepatide versus control increased the odds for achievement of normoglycemia by >16 times.
引用
收藏
页数:3
相关论文
共 50 条